Last edition
News about "John Wilding"
Lilly's Zepbound Shows More Weight Loss Than Wegovy HD in Analysis
Lilly’s Zepbound (tirzepatide 10 mg and 15 mg) was associated with greater weight loss than Wegovy HD (semaglutide 7.2 mg) in an indirect comparison.
John Wilding | 01/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members